StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30123% above fair value
$17.42+0.20 (+1.16%)

Close on Nov 20, 2026Market cap $475.61MP/E –Yield –

Carlsmed gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Carlsmed's gross profit for the twelve months ending Jun 30, 2026 was $48.50M, up 71.2% year over year. For fiscal 2025 it was $38.04M, up 89.7% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$38.04M+89.7%
FY2024Dec 31, 2024$20.05M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.54M+64.0%
Q1 FY2026Mar 31, 2026$12.43M+62.7%
Q4 FY2025Dec 31, 2025$11.61M+65.3%
Q3 FY2025Sep 30, 2025$9.93M+106.9%
Q2 FY2025Jun 30, 2025$8.87M+94.4%
Q1 FY2025Mar 31, 2025$7.64M–
Q4 FY2024Dec 31, 2024$7.02M–
Q3 FY2024Sep 30, 2024$4.80M–
Q2 FY2024Jun 30, 2024$4.56M–

More Carlsmed figures

See a number that looks wrong?